Literature DB >> 1922830

Clozapine is beneficial for psychosis in Parkinson's disease.

N Kahn1, A Freeman, J L Juncos, D Manning, R L Watts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1922830     DOI： 10.1212/wnl.41.10.1699

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 2.  Antiparkinsonian agents. Drug interactions of clinical significance.

Authors:  R F Pfeiffer
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 3.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

Review 4.  Treatment of psychosis in Parkinson's disease: safety considerations.

Authors:  Hubert H Fernandez; Martha E Trieschmann; Joseph H Friedman
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Drug-induced mania in the elderly.

Authors:  L Ganzini; S B Millar; J R Walsh
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.